Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia

NCT04296214 · clinicaltrials.gov ↗

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Poor recruitment

Conditions

Myelodysplastic Syndromes
Acute Myeloid Leukemia

Interventions

DRUG: 5-azacitidine

Sponsor

Grupo Cooperativo de Hemopatías Malignas